{"title_page": "FG-7142", "text_new": "{{chembox\n| Verifiedfields = changed\n| Watchedfields = changed\n| verifiedrevid = 426209057\n| ImageFile = FG-7142.svg\n| ImageSize = 200px\n| IUPACName = ''N''-Methyl-9''H''-pyrido[5,4-''b'']indole-3-carboxamide\n| OtherNames = ZK-31906\n\n| Section1 = {{Chembox Identifiers\n| CASNo_Ref = {{cascite|correct|??}}\n| CASNo = 78538-74-6\n| PubChem = 4375\n| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}\n| ChemSpiderID = 4222\n| MeSHName = C526324\n| SMILES=CNC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2\n| StdInChI_Ref = {{stdinchicite|changed|chemspider}}\n| StdInChI = 1S/C13H11N3O/c1-14-13(17)11-6-9-8-4-2-3-5-10(8)16-12(9)7-15-11/h2-7,16H,1H3,(H,14,17)\n| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}\n| StdInChIKey = QMCOPDWHWYSJSA-UHFFFAOYSA-N\n| UNII_Ref = {{fdacite|changed|FDA}}\n| UNII = 60PO70N1BP\n  }}\n\n| Section2 = {{Chembox Properties\n| Formula = C<sub>13</sub>H<sub>11</sub>N<sub>3</sub>O\n| MolarMass = 225.24594\n| Appearance =\n| Density =\n| MeltingPt =\n| BoilingPt =\n| Solubility =\n  }}\n\n| Section3 = {{Chembox Hazards\n| MainHazards =\n| FlashPt =\n| AutoignitionPt =\n  }}\n}}\n\n'''FG-7142''' ('''ZK-31906''') is a drug which acts as a partial [[inverse agonist]] at the [[benzodiazepine]] [[allosteric]] site of the [[GABAA receptor|GABA<sub>A</sub> receptor]].<ref name=\"pmid17503486\">{{cite journal |vauthors=Stevenson CW, Halliday DM, Marsden CA, Mason R |title=Systemic administration of the benzodiazepine receptor partial inverse agonist FG-7142 disrupts corticolimbic network interactions |journal=Synapse |volume=61 |issue=8 |pages=646\u201363 |year=2007 |pmid=17503486 |doi=10.1002/syn.20414|citeseerx=10.1.1.323.5370 }}</ref> It has [[anorectic]],<ref>{{cite journal | vauthors = Cottone P, Sabino V, Steardo L, Zorrilla EP | date = May 2007 | title = FG 7142 specifically reduces meal size and the rate and regularity of sustained feeding in female rats: evidence that benzodiazepine inverse agonists reduce food palatability | url = | journal = Neuropsychopharmacology | volume = 32 | issue = 5| pages = 1069\u201381 | pmid = 17077811 | doi = 10.1038/sj.npp.1301229 }}</ref> [[anxiogenic]] and pro-[[convulsant]] effects.<ref>{{cite journal | vauthors = Evans AK, Lowry CA | date = Winter 2007 | title = Pharmacology of the beta-carboline FG-7,142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects | url = | journal = CNS Drug Reviews | volume = 13 | issue = 4| pages = 475\u2013501 | pmid = 18078430 | doi = 10.1111/j.1527-3458.2007.00025.x }}</ref> It also increases release of [[acetylcholine]] and [[noradrenaline]],<ref>{{cite journal | vauthors = Claustre Y, Rouquier L, Desvignes C, Leonetti M, Mont\u00e9gut J, Aubin N, Allouard N, Bougault I, Oury-Donat F, Steinberg R | year = 2006 | title = Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat | url = | journal = Neuroscience | volume = 141 | issue = 3| pages = 1481\u20138 | pmid = 16781820 | doi = 10.1016/j.neuroscience.2006.05.006 }}</ref> and improves memory retention in animal studies.<ref>{{cite journal | vauthors = McNally GP, Augustyn KA, Richardson R | year = 2008 | title = GABA(A) receptors determine the temporal dynamics of memory retention | journal = Learning and Memory | volume = 15 | issue = 3| pages = 106\u201311 | pmid = 18285469 | doi = 10.1101/lm.806008 | pmc = 2275652 }}</ref>\n\n==References==\n{{reflist|30em}}\n\n{{GABAergics}}\n{{Convulsants}}\n\n[[Category:Anxiogenics]]\n[[Category:Beta-Carbolines]]\n[[Category:Carboxamides]]\n[[Category:Convulsants]]\n[[Category:GABAA receptor negative allosteric modulators]]\n[[Category:Nootropics]]\n\n\n{{biochem-stub}}\n", "text_old": "{{chembox\n| Verifiedfields = changed\n| Watchedfields = changed\n| verifiedrevid = 426209057\n| ImageFile = FG-7142.svg\n| ImageSize = 200px\n| IUPACName = ''N''-Methyl-9''H''-pyrido[5,4-''b'']indole-3-carboxamide\n| OtherNames = ZK-31906\n\n| Section1 = {{Chembox Identifiers\n| CASNo_Ref = {{cascite|correct|??}}\n| CASNo = 78538-74-6\n| PubChem = 4375\n| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}\n| ChemSpiderID = 4222\n| MeSHName = C526324\n| SMILES=CNC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2\n| StdInChI_Ref = {{stdinchicite|changed|chemspider}}\n| StdInChI = 1S/C13H11N3O/c1-14-13(17)11-6-9-8-4-2-3-5-10(8)16-12(9)7-15-11/h2-7,16H,1H3,(H,14,17)\n| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}\n| StdInChIKey = QMCOPDWHWYSJSA-UHFFFAOYSA-N\n| UNII_Ref = {{fdacite|changed|FDA}}\n| UNII = 60PO70N1BP\n  }}\n\n| Section2 = {{Chembox Properties\n| Formula = C<sub>13</sub>H<sub>11</sub>N<sub>3</sub>O\n| MolarMass = 225.24594\n| Appearance =\n| Density =\n| MeltingPt =\n| BoilingPt =\n| Solubility =\n  }}\n\n| Section3 = {{Chembox Hazards\n| MainHazards =\n| FlashPt =\n| AutoignitionPt =\n  }}\n}}\n\n'''FG-7142''' ('''ZK-31906''') is a drug which acts as a partial [[inverse agonist]] at the [[benzodiazepine]] [[allosteric]] site of the [[GABAA receptor|GABA<sub>A</sub> receptor]].<ref name=\"pmid17503486\">{{cite journal |vauthors=Stevenson CW, Halliday DM, Marsden CA, Mason R |title=Systemic administration of the benzodiazepine receptor partial inverse agonist FG-7142 disrupts corticolimbic network interactions |journal=Synapse |volume=61 |issue=8 |pages=646\u201363 |year=2007 |pmid=17503486 |doi=10.1002/syn.20414|citeseerx=10.1.1.323.5370 }}</ref> It has [[anorectic]],<ref>Cottone P, Sabino V, Steardo L, Zorrilla EP. FG 7142 specifically reduces meal size and the rate and regularity of sustained feeding in female rats: evidence that benzodiazepine inverse agonists reduce food palatability. ''Neuropsychopharmacology''. 2007 May;32(5):1069-81. {{PMID|17077811}}</ref> [[anxiogenic]] and pro-[[convulsant]] effects.<ref>Evans AK, Lowry CA. Pharmacology of the beta-carboline FG-7,142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects. ''CNS Drug Reviews''. 2007 Winter;13(4):475-501. {{PMID|18078430}}</ref> It also increases release of [[acetylcholine]] and [[noradrenaline]],<ref>Claustre Y, Rouquier L, Desvignes C, Leonetti M, Mont\u00e9gut J, Aubin N, Allouard N, Bougault I, Oury-Donat F, Steinberg R. Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat. ''Neuroscience''. 2006 Sep 1;141(3):1481-8. {{PMID|16781820}}</ref> and improves memory retention in animal studies.<ref>McNally GP, Augustyn KA, Richardson R. GABA(A) receptors determine the temporal dynamics of memory retention. ''Learning and Memory''. 2008 Feb 19;15(3):106-11. {{PMID|18285469}}</ref>\n\n==References==\n{{reflist|30em}}\n\n{{GABAergics}}\n{{Convulsants}}\n\n[[Category:Anxiogenics]]\n[[Category:Beta-Carbolines]]\n[[Category:Carboxamides]]\n[[Category:Convulsants]]\n[[Category:GABAA receptor negative allosteric modulators]]\n[[Category:Nootropics]]\n\n{{biochem-stub}}\n", "name_user": "Rjwilmsi", "label": "safe", "comment": "Journal cites:, added 2 DOIs, templated 2 journal cites", "url_page": "//en.wikipedia.org/wiki/FG-7142"}
